Philippe Truffinet

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Paul O’Connor, Jerry S. Wolinsky, Christian Confavreux et al. · New England Journal of Medicine · 2011 · 976 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Christian Confavreux, Paul O’Connor, Mark Freedman et al. · The Lancet Neurology · 2014 · 570 citations

Pharmacy, Neurology, Pharmacotherapy +10

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi et al. · Multiple Sclerosis Journal · 2013 · 351 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Aaron Miller, Jerry S. Wolinsky, Ludwig Kappos et al. · The Lancet Neurology · 2014 · 298 citations

Life Sciences, Neurology, Pharmacotherapy +7

A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis

Gilbert Bensimon, Lucette Lacomblez, Jean-Christophe Delumeau et al. · Journal of Neurology · 2002 · 171 citations

Medicine, Neurology, Pharmacology +11